Andrew Obenshain
Director Ejecutivo en BLUEBIRD BIO, INC. .
Fortuna: 255 638 $ al 30/04/2024
Perfil
Andrew Obenshain is currently the President, Chief Executive Officer & Director at bluebird bio, Inc. since 2021.
He is also currently serving as a Director at bluebird bio (UK) Ltd.
since 2017.
Previously, he worked as the General Manager-Finance at Shire France SAS.
Mr. Obenshain completed his undergraduate degree at Dartmouth College and holds an MBA from Kellogg School of Management.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BLUEBIRD BIO, INC.
0.15% | 04/03/2024 | 279 998 ( 0.15% ) | 255 638 $ | 30/04/2024 |
Cargos activos de Andrew Obenshain
| Empresas | Cargo | Inicio |
|---|---|---|
| BLUEBIRD BIO, INC. | Director Ejecutivo | 04/11/2021 |
bluebird bio (UK) Ltd.
 bluebird bio (UK) Ltd. BiotechnologyHealth Technology Founded in 2016, bluebird bio (UK) Ltd. is a British biotechnology company that engages in research and development. The company is based in Basingstoke, UK and is a subsidiary of bluebird bio, Inc. | Director/Miembro de la Junta | 30/03/2017 |
Antiguos cargos conocidos de Andrew Obenshain.
| Empresas | Cargo | Fin |
|---|---|---|
Shire France SAS
 Shire France SAS Pharmaceuticals: MajorHealth Technology Shire France SA manufactures pharmaceutical products. The firm offers prescriptions and proprietary drugs. It specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, and genetic diseases. The company was founded in 1997 and is headquartered in Paris, France. | Corporate Officer/Principal | - |
Formación de Andrew Obenshain.
| Kellogg School of Management | Masters Business Admin |
| Dartmouth College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
bluebird bio (UK) Ltd.
bluebird bio (UK) Ltd. BiotechnologyHealth Technology Founded in 2016, bluebird bio (UK) Ltd. is a British biotechnology company that engages in research and development. The company is based in Basingstoke, UK and is a subsidiary of bluebird bio, Inc. | Health Technology |
Shire France SAS
Shire France SAS Pharmaceuticals: MajorHealth Technology Shire France SA manufactures pharmaceutical products. The firm offers prescriptions and proprietary drugs. It specializes in therapeutic areas such as hematology, nephrology, central nervous system, gastrointestinal, and genetic diseases. The company was founded in 1997 and is headquartered in Paris, France. | Health Technology |
- Bolsa de valores
- Insiders
- Andrew Obenshain